Back to results
US 6,258,838 B1Granted
Compounds
AssigneeAstraZeneca AB
InventorsAndrew Baxter, Thomas McInally, Michael Mortimore, David Cladingboel
Life of this patent
Estimating the term…
Abstract
The invention provides adamantane derivatives, a process for their preparation, pharmaceutical compositions containing them, a process for preparing the pharmaceutical compositions, and their use in therapy.
Claims9
A compound of general formula
- wherein
- x represents 1 or 2;
- A represents an oxygen atom;
- B represents a hydrogen or halogen atom;
- R represents a phenyl, pyridyl, indolyl, indazolyl, pyrimidinyl or thienyl group, each of which may be optionally substituted by one or more substituents independently selected from a halogen atom or an amino, cyano, carboxyl, hydroxyl, nitro, C1-C6-alkyl, halo-C1-C6-alkyl, —N(R1)—C(═O)—R2, —C(O)NR3R4, —NR5R6, C3-C8-cycloalkyl, 3- to 8-membered heterocyclyl, C3-C8-cycloalkyloxy, C1-C6-alkylcarbonyl, C1-C6-alkoxycarbonyl, C1-C6-alkylsulphinyl or C1-C6-alkylsulphonyl group, or a C1-C6-alkoxy, C1-C6-alkylamino, phenoxy, benzyl, C1-C6-alkylthio or phenylthio group optionally substituted by one or more substituents independently selected from a halogen atom or an amino, cyano, carboxyl, hydroxyl, nitro, 1-pyrrolidinyl, 1-piperidinyl, C1-C6-alkyl, C1-C6-alkoxy, (di)C1-C6-alkylamino, halo-C1-C6-alkyl, C1-C6-alkoxycarbonyl or one of the following groups:
- R1 represents a hydrogen atom or a C1-C6-alkyl or C3-C8-cycloalkyl group;
- R2 represents a C1-C6-alkyl or C3-C8-cycloalkyl group;
- R3 and R4 each independently represent a hydrogen atom or a C1-C6-alkyl or C3-C8-cycloalkyl group;
- R5 represents a hydrogen atom or a C1-C6-alkyl or C3-C8-cycloalkyl group;
- R6 represents a C3-C8-cycloalkyl group and, additionally, a C1-C6-alkyl group when R5 is not a hydrogen atom;
- R7 represents a hydrogen atom or a C1-C6-alkyl or C3-C8-cycloalkyl group;
- R8 represents a C1-C6-alkyl or C3-C8-cycloalkyl group;
- R9 represents a hydrogen atom or a hydroxyl group;
- and
- R10 represents a hydrogen atom or a phenyl or imidazolyl group;
- with the proviso that when R represents a substituted phenyl, indolyl or indazolyl group, the substituent or substituents present do not comprise an amido, carboxyl, (di)C1-C6-alkylamido or C1-C6-alkoxycarbonyl group in an ortho position;
- or a pharmaceutically acceptable salt or solvate thereof.
14 more elements
Dependencies are inferred from the claim text.